title: Ultrasonically guided transvaginal oocyte recovery from calves treated with or without GnRH.
abstract: We investigated the effect of GnRH given after gonadotropin stimulation on follicle growth and oocyte quality in young calves in a transvaginal oocyte recovery program. A 60 mg MPA pessary was inserted into each of nineteen 5-mo-old Friesian calves for 7 d; on Day 5 they received 140 mg, s.c. FSH (Folltropin) and 200 IU, i.m. PMSG and on Day 8 ten of the calves received 40 micrograms, i.m. GnRH (Fertagyl). Follicles were measured and aspirated on Day 9 using an ultrasound unit with a 6 MHz transvaginal probe (Toshiba). Oocytes from individual calves were recovered, graded and cultured in maturation media for 2 h (+GnRH group) or 22 h (-GnRH group), then fertilized and cultured for 6 d in SOF containing 0.8% BSA and amino acids. Oocyte viability (Class A,B or C) and embryo morphology were recorded. This procedure was repeated on the 19 calves plus 5 others 1 m.o. later, after random allocation to their respective groups. Approximately 70% of the calves responded to gonadotropin stimulation (> 2 follicles over 5 mm in diameter). Calves receiving GnRH tended to have both a higher number of follicles > 2 mm in diameter (27.1 vs 18.7) and of aspirated follicles (22.0 vs 14.1); however, there was a large variability between individuals (0 to 83 follicles and 0 to 73 aspirated). The total number of oocytes collected (10.8 vs 10.9) was not affected by GnRH treatment, probably due to the poor recovery rates in the highly stimulated calves from the +GnRH group, but GnRH did improve the proportion of viable oocytes (6.5 vs 4.1) due to a lower number of Class E oocytes (1.4 vs 4.5; P < 0.05). In the GnRH group, 40% of the viable oocytes had matured at the time of collection versus 0% in the group not treated with GnRH. The necessity of different culture runs between times and treatments prevented any meaningful comparison between groups for embryo development. Following the transfer of 19 morula/blastocyst-stage embryos to recipients, 3 pregnancies were detected by ultrasound examination on Day 60, with 1 oocyte originating from the +GnRH group and 2 from the -GnRH group.
authors.affiliation: Victorian Institute of Animal Science, Victoria, Australia.
authors.forename: R C
authors.initials: RC
authors.lastname: Fry
authors.forename: T L
authors.initials: TL
authors.lastname: Simpson
authors.forename: T J
authors.initials: TJ
authors.lastname: Squires
mesh_terms: D000282:Administration, Intravaginal; D000367:Age Factors; D000818:Animals; D002417:Cattle / Q000196:embryology / Q000502:physiology*; D004624:Embryo Transfer / Q000662:veterinary*; D005314:Embryonic and Fetal Development / Q000502:physiology; D005260:Female; D005307:Fertilization in Vitro / Q000662:veterinary*; D005640:Follicle Stimulating Hormone / Q000494:pharmacology / Q000502:physiology; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology* / Q000502:physiology; D006064:Gonadotropins, Equine / Q000494:pharmacology; D008297:Male; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage; D009865:Oocytes / Q000187:drug effects* / Q000502:physiology; D006080:Ovarian Follicle / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000502:physiology; D011247:Pregnancy; D045167:Progesterone Congeners / Q000008:administration & dosage; D011897:Random Allocation; D014463:Ultrasonography; D014621:Vagina / Q000000981:diagnostic imaging
chemical_list: D006064:Gonadotropins, Equine; D045167:Progesterone Congeners; D007987:Gonadotropin-Releasing Hormone; D005640:Follicle Stimulating Hormone; D017258:Medroxyprogesterone Acetate